Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001894156 | SCV002127372 | uncertain significance | not provided | 2024-01-02 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 81 of the THBD protein (p.Val81Ile). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with atypical hemolytic uremic syndrome (PMID: 19625716, 31118930). ClinVar contains an entry for this variant (Variation ID: 1358168). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002503399 | SCV002779195 | uncertain significance | Atypical hemolytic-uremic syndrome with thrombomodulin anomaly; Thrombomodulin-related bleeding disorder | 2022-03-24 | criteria provided, single submitter | clinical testing |